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Abstract
Current guidelines recommend patients 
with POTS be prescribed an exercise 
regimen as first line therapy. If this is not 
effective, patients should then be 
prescribed a recommended 
pharmacotherapy. Through a literature 
search, only studies involving 3 of the 
several pharmacotherapies could be found. 
Therefore, Propranolol, Desmopressin, and 
Midodrine were only evaluated in this 
review. Although more research is needed, 
exercise remains the most efficacious 
compared to pharmacotherapy. However, if 
exercise alone is not enough, using 
Propranolol or Desmopressin may reduce 
symptoms in patients with POTS. 
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Postural Orthostatic Tachycardia Syndrome 
(POTS) is a condition of chronic orthostatic 
intolerance which is associated with 
lightheadedness, palpitations, 
tremulousness, generalized weakness, 
blurred vision, exercise intolerance, and 
fatigue upon standing. This paper will 
address the efficacy of several 
recommended pharmacotherapy options, 
compared to the first line treatment of 
exercise, to understand how to improve 
symptoms and quality of life in female 
patients of childbearing age with POTS.
Introduction
Methods
A literature search was conducted through 
PubMed and ClinicalKey in November 
2019. Seven articles were selected based 
on their relevance to the research question, 
study design, outcome measurements, and 
results
Limited sample populations, lack of long-
term data, and lack of selection from a 
broader pool of patients limit all findings 
from a higher statistical power of evidence. 
The findings support current guidelines to 
implement exercise as a first line therapy in 
patients with POTS. Furthermore, they 
provide additional insight into which 
medications, in this case Propranolol, and 
Desmopressin, have evidence to support their 
efficacy at reducing symptoms in POTS. No 
negative health outcomes were recorded as a 
result of any of these studies and this topic of 
study should be encouraged to continue to 
look at long term data with larger sample 
populations. 
Discussion Results 
The Efficacy of Non-Pharmaceutical Therapy in the Treatment 
of Postural Orthostatic Tachycardia Syndrome
The evidence gathered in this investigation 
supports the current guidelines. However, it is 
important to consider that through this 
investigation only two of the 
pharmacotherapy options provided statistical 
evidence of being effective in patients with 
POTS. These medications were Propranolol, 
a beta blocker, and Desmopressin, a 
vasopressor. 
These result should encourage providers to 
familiarize themselves with specific exercise 
programs designed to target the 
cardiovascular deconditioning associated 
with POTS. 
Further studies should aim to include larger 
sample sizes and longer duration of studies to 
assess long term impact of exercise and 
pharmacotherapy on patients with POTS. 
Conclusion
1. Arnold et al. Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study. (2013)
Ø A randomized double-blind cross over study with 16 participants to assess the effects of oral-low dose propranolol vs. placebo on 
exercise capacity in patients with POTS and healthy subjects. Data suggests mechanism by which propranolol is working is to 
increase the exercise capacity overall by increasing the stroke volume. 
2. Coffin et al. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. 
(2012)
ØA randomized single-blind crossover study to determine if Desmopressin (DDAVP) could promote blood volume expansion in 
patients with POTS therefore reducing upright tachycardia and improving patients’ symptoms. DDAVP significantly decreased 
tachycardia and improved symptoms in POTS.
3. Fu et al. Exercise training versus propranolol in the treatment of postural orthostatic tachycardia syndrome. (2011)
ØA double-blind trial with 19 participants comparing propranolol and placebo followed by 3 months of exercise training. Short-term 
exercise training is superior to Beta blockade due to overall effect on adrenal function. 
4. George et al. The international POTS registry: evaluating the efficacy of an exercise training intervention in a community
setting. (2016)
ØTo determine if the efficacy of an exercise training program on POTS patients would be effective within a community setting. 
Exercise in a community setting is an effective treatment for POTS, improvement in quality of life in some patients, and seeing 
remission in some patients. 
5. Lai et al. Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and 
beta‐blockers. (2009) 
ØA retrospective study of 121 participants to determine efficacy and impact of specific drug therapies used for patients with POTS 
to assess their functionality to improve quality of life. Treatment with midodrine and beta-blockers was associated with overall
improvement, but beta-blockers were more likely to improve quality of life. 
6. Ross et al. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic 
compared with hyperadrenergic postural tachycardia syndrome. (2014) 
ØA randomized placebo controlled double-blind cross-over study with 20 participants to determine if midodrine would act on 
patients with neuropathic POTS and not on those with hyperadrenergic POTS. Placebo effect was seen in patients with 
hyperadrenergic POTS, improvement only seen in patients with neuropathic POTS, but HR changes were NS.
7. Shibata et al. Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic 
tachycardia syndrome. (2012)
ØA study with 19 participants to determine if physical deconditioning, or cardiac atrophy, along with reduced blood volume, 
contributed to the pathogenesis of POTS. And if short term exercise training programs would help to improve cardiovascular 
response to exercise in the patients. Short term exercise (3 months) improved cardiovascular response in patients with POTS.
Study Reduction of POTS 
Symptoms
HR changes VO2 max CO
1 N/A S NS NS
2 S S N/A N/A




N/A NS – exercise
S - propranolol
4 S S N/A N/A
5 S – beta blocker
S - midodrine
N/A N/A N/A
6 N/A NS N/A N/A
7 N/A S S S
Key: S – significant and NS – not significant
